Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celularity (CELU) EPS (Basic) (2020 - 2025)

Celularity has reported EPS (Basic) over the past 6 years, most recently at -$0.85 for Q4 2025.

  • Quarterly EPS (Basic) fell 44.07% to -$0.85 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.59 through Dec 2025, down 35.47% year-over-year, with the annual reading at -$3.59 for FY2025, 35.98% down from the prior year.
  • EPS (Basic) was -$0.85 for Q4 2025 at Celularity, up from -$0.88 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $1.08 in Q4 2022 and troughed at -$4.98 in Q3 2023.
  • The 5-year median for EPS (Basic) is -$0.78 (2024), against an average of -$1.07.
  • Year-over-year, EPS (Basic) soared 142.86% in 2021 and then tumbled 16700.0% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at $0.51 in 2021, then surged by 111.76% to $1.08 in 2022, then decreased by 22.22% to $0.84 in 2023, then crashed by 170.24% to -$0.59 in 2024, then plummeted by 44.07% to -$0.85 in 2025.
  • Per Business Quant, the three most recent readings for CELU's EPS (Basic) are -$0.85 (Q4 2025), -$0.88 (Q3 2025), and -$1.02 (Q2 2025).